Jefferies lowers Colgate-Palmolive stock price target on cost concerns By Investing.com

Jefferies cut Colgate-Palmolive’s price target to $88 from $91 and reiterated a Hold rating, while trimming its 2026 EPS growth estimate to 3% from 5% and signaling the company may guide to the low end of its range. The note highlights rising input costs and demand sensitivity as key risks, with inflation concerns echoed by recent broker action. Separately, Colgate announced a legal leadership transition, with Jennifer M. Daniels set to retire in 2026 and Betsy Fishbone taking over effective June 1, 2026.

Analysis

The setup is less about one quarter and more about margin durability. When a defensive staple starts hearing repeated chatter about input inflation and demand elasticity, the market is implicitly pricing a slower earnings compounding path rather than an outright deterioration; that usually compresses the multiple before it shows up in the P&L. The key second-order effect is that private label and smaller regional brands can gain shelf share if management leans too hard on price to defend gross margin, especially in lower-income geographies and club channels.

The most important catalyst is not the reported quarter but forward commentary: if guidance is merely reaffirmed while the language around the back half gets more guarded, that often keeps valuation capped for several months even if the print is fine. A low-end guide would likely force estimate cuts to cascade through the rest of the consumer staples group, because investors tend to treat this category as a read-through on elasticity and commodity pass-through discipline. Conversely, if management can show mix, productivity, and hedging offsetting cost pressure, the stock can re-rate quickly because the market is already positioned for caution.

The contrarian view is that the negative revision cycle may already be largely in the price. For a company with defensive cash flow, the bigger upside surprise is not faster top-line growth but evidence that inflation is peaking while demand remains stable, which would restore confidence in the dividend-and-buyback story. That makes this a candidate for a tactical short only if the next update confirms margin pressure is extending beyond the next quarter; otherwise, the risk/reward starts to favor waiting for a better entry rather than chasing downgrade momentum.

Key Decisions for Investors

• Stay underweight CL into the next print; use any pre-earnings bounce to initiate a tactical short or buy puts for a 1-3 month horizon, targeting a 5-8% downside if guidance lands at the low end of the range.
• Pair trade: long PG / short CL for 4-8 weeks to isolate relative margin resilience in branded staples; this works if investors continue rewarding cleaner pass-through and less guidance risk.
• If CL sells off hard on reaffirmed guidance, consider covering shorts and pivoting to a small long in the $80-$82 area; risk/reward improves if the market has already priced multiple estimate cuts.
• For options traders, prefer a bearish put spread over outright shorts into earnings commentary; implied volatility should remain elevated, and the thesis only needs a modest miss in tone, not numbers.